Growth Metrics

Sarepta Therapeutics (SRPT) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 2.20%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.20%
Dec 31, 2025 48.45%
Sep 30, 2025 19.97%
Jun 30, 2025 71.28%
Mar 31, 2025 -80.45%
Dec 31, 2024 54.83%
Sep 30, 2024 6.85%
Jun 30, 2024 50.18%
Mar 31, 2024 -10.85%
Dec 31, 2023 28.68%
Sep 30, 2023 18.17%
Jun 30, 2023 -3.40%
Mar 31, 2023 -33.02%
Dec 31, 2022 17.86%
Sep 30, 2022 1.62%
Jun 30, 2022 7.43%
Mar 31, 2022 13.08%
Dec 31, 2021 39.53%
Sep 30, 2021 -0.04%
Jun 30, 2021 2.98%
Mar 31, 2021 -61.51%
Dec 31, 2020 -79.79%
Sep 30, 2020 -64.99%
Jun 30, 2020 -12.93%
Mar 31, 2020 128.45%
Dec 31, 2019 -29.10%
Sep 30, 2019 -7.74%
Jun 30, 2019 -29.85%
Mar 31, 2019 -37.98%
Dec 31, 2018 -63.96%
Sep 30, 2018 -41.13%
Jun 30, 2018 -62.84%
Mar 31, 2018 -2.92%
Dec 31, 2017 -6.93%
Sep 30, 2017 -7.08%
Jun 30, 2017 -25.98%
Mar 31, 2017 -22.90%
Dec 31, 2016 -65.90%
Sep 30, 2016 -42.57%
Jun 30, 2016 -52.07%
Mar 31, 2016 -60.35%
Dec 31, 2015 -65.35%
Sep 30, 2015 -82.80%
Jun 30, 2015 -71.17%
Mar 31, 2015 -69.20%
Dec 31, 2014 -69.67%
Sep 30, 2014 -82.82%
Jun 30, 2014 -266.93%
Mar 31, 2014 -48.33%
Dec 31, 2013 -106.53%
Sep 30, 2013 -90.63%